INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 May 2011
|
Total net assets |
£104.2m |
|
NAV per share |
179.6p |
|
Share price |
152.8p |
|
Total value of unquoted investments |
£24.9m |
|
Total number of portfolio companies |
60 |
|
Cash |
3% NAV |
|
Cash committed and reserved to unquoted investments |
8% NAV |
|
Portfolio companies with < 1 year of cash |
9% NAV |
Top Ten Holdings
|
Company Name |
% NAV |
|
Amgen |
5.97 |
|
Teva |
5.83 |
|
Cadent |
5.31 |
|
Gilead Sciences |
4.61 |
|
Insulet |
4.50 |
|
Celgene |
4.26 |
|
Micromet |
3.77 |
|
Shire Ltd |
3.77 |
|
Aptiv |
2.62 |
|
Pharmasset |
2.44 |
|
|
----------- |
|
Total |
43.08 |
|
Geographical Allocation |
% |
|
United States |
69 |
|
Europe |
21 |
|
Israel |
6 |
|
Australia |
1 |
|
Cash |
3 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted allocation |
% |
|
Quoted |
73 |
|
Unquoted |
24 |
|
Cash |
3 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
16 JUNE 2011